Heartbeat in a Petri Dish: How Organoids Are Revolutionizing Research

A functional, autonomously beating mini heart in a Petri dish – smaller than the head of a pin and even equipped with its own immune system. What sounded like science fiction just a few years ago is now a fascinating reality in modern research laboratories. Organoids – three-dimensional miniature models of human organs grown in the laboratory – are revolutionizing biomedical research. By more accurately replicating the architecture and function of human tissues, they bridge the gap between conventional two-dimensional cell cultures and complex animal models. These “mini organs” are fundamentally changing the way we study diseases, develop new therapies, and pave the way toward personalized medicine.

How far this technology has advanced is demonstrated by a recent breakthrough in German research: Scientists at the Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM) and Hannover Medical School have successfully developed cardiac organoids that not only beat rhythmically but also possess their own functional immune system (Fig. 1). These innovative mini hearts make it possible, for the first time, to investigate the potential cardiotoxicity of new drug candidates directly in human cardiac tissue. As many promising therapeutics – particularly in oncology – fail during the later stages of development due to adverse effects on the heart, these “Hannover mini hearts” represent a major advance in preclinical research [1].

But how are these fascinating mini organs created? How can just a handful of stem cells give rise to three-dimensional tissue structures that faithfully reproduce not only the architecture but also key functions of a human organ?

1) From Cell to Organ: The Secret of Self-Organization

2) The Challenge of Reproducibility

3) Architecture for Mini Organs: Tailored Matrices for Stable Organoid Cultures from Amsbio

4) Molecular Farming for Organoid Research: Animal-Free Growth Factors from ORF Genetics

From Cell to Organ: The Secret of Self-Organization

Today, organoids can be generated for a wide variety of human tissues, including models of the heart, stomach, intestine, kidney, and even complex structures of the brain [2]. They are typically derived from embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), or tissue-specific adult stem cells [3]. What these cells have in common is their ability to differentiate into a wide range of cell types and, under the right conditions, assemble into highly organized tissue structures. One of the defining features of organoids is their remarkable capacity for self-organization. Stem cells possess an intrinsic genetic program that governs their spatial organization, cell-cell communication, and differentiation. When provided with the appropriate biochemical and physical cues, they spontaneously form three-dimensional tissue structures that recapitulate key features of their native counterparts. In conventional two-dimensional cell cultures, however, much of this potential is lost. Cells grown on the rigid plastic surface of standard culture dishes adopt a flattened morphology and communicate differently than they do in living tissue. As a result, they fail to accurately reproduce either the complex architecture or the functional properties of a human organ.

For stem cells to develop into a functional mini organ – such as the cardiac organoids created by the Fraunhofer team – the laboratory environment must closely replicate the conditions cells encounter within the human body. Both the physical environment and biochemical signaling are essential for this process [4]. First, cells require a three-dimensional scaffold that allows them to attach, orient themselves, and organize into complex tissue structures. These matrices mimic the properties of the natural extracellular matrix (ECM) – a complex network of proteins and other molecules that provides structural support to tissues while profoundly influencing cell behavior. Equally important is the precise control of cell differentiation. By adding specific signaling proteins, known as growth factors, in a carefully controlled spatial and temporal manner, stem cells receive the developmental cues needed to differentiate into defined cell types. When these physical and biochemical conditions are optimally coordinated, the remarkable process of self-organization unfolds: cells spontaneously assemble into complex three-dimensional tissues and give rise to organ-specific structures such as neuronal networks, vascular structures, and contractile cardiac muscle tissue (Fig. 1).

Figure 1: Functional, autonomously beating cardiac organoid [1]. The mini heart, developed by the Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM) and Hannover Medical School, consists of cardiomyocytes (cardiac muscle cells, pink), cardiac fibroblasts (connective tissue cells, yellow), and endothelial cells (vascular cells; nuclei shown in blue). Together, these cell types form a three-dimensional cardiac tissue that recapitulates key structural and functional features of the human heart. Copyright: © Fraunhofer ITEM

The Challenge of Reproducibility

As revolutionary as organoid technology is, one of its greatest challenges remains reproducibility. To be used as reliable models in drug development, toxicology, or disease research, organoids must be cultivated under precisely defined and standardized conditions. Even minor variations in cell culture procedures, culture media, or matrices can influence organoid development and function, limiting the comparability of experimental results. The Helmholtz Centre for Infection Research (HZI) in Braunschweig demonstrates how this challenge can be addressed. There, the cell culture robot Molly enables the automated production of organoids. Operating around the clock, the system can cultivate up to 40,000 organoids per month while ensuring high process consistency – a crucial prerequisite for reproducible experiments and meaningful analyses [5].

In addition to precise automation, the quality of the reagents used plays a crucial role. Growth factors and cell culture matrices must meet the highest standards for purity, stability, and lot-to-lot consistency. Even minor variations can affect cell differentiation, lead to the formation of undesired cell types, or compromise the structural integrity of organoids. Reliable and reproducible organoid cultures therefore require high-quality, standardized cell culture components. Together with our partners Amsbio and ORF Genetics, Biomol provides a portfolio of specialized matrices, recombinant growth factors, and other cell culture reagents that support researchers in establishing robust organoid models.

Architecture for Mini Organs: Tailored Matrices for Stable Organoid Cultures from Amsbio

Our partner Amsbio provides the essential biological building blocks for your organoid culture. With iMatrix, a series of recombinant laminin E8 fragments, defined and xeno-free cell culture substrates are available that are specifically designed to support different cell types and differentiation processes. Laminins are important extracellular matrix proteins that serve as adhesion substrates for numerous cell types. Through their E8 domain, they interact with integrin receptors on the cell surface and thereby regulate key cellular processes such as attachment, proliferation, and differentiation [6].

The iMatrix products mimic these natural ECM signals, creating a controlled environment in which cells can develop according to their biological properties. The iMatrix series from Amsbio includes highly purified, recombinant E8 fragments of various laminin isoforms (laminin-511, -111, -221, -332, and -411). These substrates enable the targeted optimization of cell culture conditions and support the development of different organoid models by reproducing the signals of the natural cellular environment in vivo (Fig. 2).

Figure 2: The iMatrix series from Amsbio supports the targeted differentiation of induced pluripotent stem cells (iPSCs) into cell types derived from the three germ layers: ectoderm, mesoderm, and endoderm [6]. iMatrix-511: Maintenance and expansion of pluripotent stem cells. iMatrix-411: Induction of differentiation of ES/iPS cells into vascular endothelial cells. iMatrix-221: Enrichment and maintenance of cardiomyocytes and skeletal muscle cells. iMatrix-332: Induction of differentiation of iPS cells into corneal epithelial cells. iMatrix-111: Induction of differentiation of human iPS cells into hepatoblast-like cells. 

Molecular Farming for Organoid Research: Animal-Free Growth Factors from ORF Genetics

To provide high-quality growth factors and cytokines, our partner ORF Genetics uses a process known as “Molecular Farming” for its ISOkine product line. In this innovative production system, recombinant proteins are produced in the seeds of barley plants. Cultivation takes place in a state-of-the-art greenhouse facility located on Icelandic lava fields with volcanic soil, powered entirely by geothermal energy.

This production approach offers significant advantages for organoid research. Since the proteins are produced in a plant-based expression system, ISOkine growth factors are naturally free from animal-derived components and are particularly suitable for defined, xeno-free cell culture applications. In addition, the products are routinely tested for bacterial endotoxins, and each batch is comprehensively characterized for its biological activity. The result is a range of highly purified, reliably reproducible growth factors with consistent biological activity – key requirements for standardized organoid models [7].

Special offer: 30 % Discount on ISOkines® from ORF Genetics! Optimize your organoid cultures with animal-free recombinant growth factors and take advantage of our exclusive discount offer today.

The journey from a single stem cell to a rhythmically beating cardiac organoid with its own immune system impressively demonstrates the potential of modern biomedicine. Organoids open up entirely new possibilities for understanding human developmental processes, modeling diseases more realistically, and developing innovative therapies with greater precision. However, reliable and functional complex 3D cell culture systems require precisely defined, high-quality cell culture components. Tailored matrices such as iMatrix products from Amsbio as well as recombinant growth factors and cytokines from ORF Genetics, provide the controlled conditions required for reproducible and high-performance organoid models.

Explore the complete portfolio of Amsbio and ORF Genetics and advance your organoid research with innovative solutions for modern 3D cell culture.

Sources

[1] https://www.fraunhofer.de/de/presse/presseinformationen/2025/mai-2025/miniherzen-herzorganoide-mit-immunsystem.html, 19.07.2026

[2] https://de.wikipedia.org/wiki/Organoid, 19.07.2026

[3] https://www.drze.de/de/forschung-publikationen/im-blickpunkt/stammzellen/module/organoide, 19.07.2026

[4] https://www.eurostemcell.org/de/organoide-was-sind-organoide-und-wie-helfen-sie-der-regenerativen-medizin, 19.07.2026

[5] https://www.helmholtz-hzi.de/media-center/newsroom/news-detailseite/mini-organe-fuer-die-medizin-der-zukunft/, 19.07.2026

[6] https://www.amsbio.com/imatrix-recombinant-laminin-series/, 20.07.2026

[7] https://www.orfgenetics.com/products/isokine, 20.07.2026

Preview Image: https://www.amsbio.com/organoid-growth-harvesting-storage/